Dianthus Therapeutics DNTH Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Dianthus Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterestAndDividend.
The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dianthus Therapeutics's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dianthus Therapeutics's interest income?
- Dianthus Therapeutics (DNTH) reported interest income of $6.27M in Q1 2026.
- How has Dianthus Therapeutics's interest income changed year-over-year?
- Dianthus Therapeutics's interest income increased by 65.3% year-over-year, from $3.79M to $6.27M.
- What is the long-term trend for Dianthus Therapeutics's interest income?
- Over 3 years (2021 to 2024), Dianthus Therapeutics's interest income has grown at a 69.7% compound annual growth rate (CAGR), from $3.56M to $17.37M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.